impact factor, citescore
logo
 

One year in review

 

One year in review 2019: idiopathic inflammatory myopathies


1, 2, 3, 4, 5, 6, 7, 8

 

  1. Rheumatology Unit, University of Pisa, Italy.
  2. Division of Rheumatology, University and IRCCS Policlinico S. Matteo Foundation of Pavia, Italy.
  3. Rheumatology Unit, Department of Experimental and Clinical Medicine, University of Florence, Italy.
  4. Division of Rheumatology, University and IRCCS Policlinico S. Matteo Foundation of Pavia, Italy.
  5. Rheumatology Unit, Department of Medicine, University of Perugia, Italy.
  6. Division of Rheumatology, Department of Medical Sciences, Santa Anna University Hospital, Ferrara, Italy.
  7. Rheumatology Unit, University of Pisa, Italy. simone.barsotti.pisa@gmail.com
  8. Division of Rheumatology, University and IRCCS Policlinico S. Matteo Foundation of Pavia, Italy.

CER12951
2020 Vol.38, N°1
PI 0001, PF 0010
One year in review

Free to view
(click on article PDF icon to read the article)

PMID: 32041680 [PubMed]

Received: 15/11/2019
Accepted : 13/01/2020
In Press: 03/02/2020
Published: 06/02/2020

Abstract

The idiopathic inflammatory myopathies (IIMs) are a rare group of immune, systemic diseases characterised by muscle inflammation and frequently by extramuscular involvement. IIMs are heterogeneous with generally a chronic or subacute onset, which vary from less severe to more serious manifestations, not always easy to diagnose and even less to manage. In the past year, many studies have been published in order to clarify disease pathogenesis and improve patient management and treatment. The purpose of this review article is to provide an overview of the new insights in pathogenesis, serological findings, clinical manifestations and treatment of IIMs, summarising the most relevant studies published over the last year.

Rheumatology Article